UNSPSC 41106104: Nuclease protection assays

UNSPSC 41106104 Nuclease protection assays is a Commodity code covering DNA extraction reagents, STR amplification kits, digital PCR systems, and related forensic laboratory consumables that state crime labs, public health agencies, and forensic facilities procure for human identification, pathogen detection, and newborn screening. State and local forensic laboratories, public health departments, and crime labs drive the procurement activity under this code, with Texas agencies appearing as repeat buyers across multiple recent solicitations issued by the Department of Public Safety Crime Lab Division, the Health and Human Services Commission, and the Department of State Health Services.

Texas and Mississippi show the heaviest recent activity. The Texas Department of Public Safety Crime Lab Division posted IFB 405-26R0017287 on July 7, 2026, seeking RapidHIT consumables for human identification with responses due July 22, 2026; the same agency posted IFB 40526R0014146 in April 2026 for 5-Dye STR Multiplex kits. The Texas Health and Human Services Commission posted IFB HHS0017640 on July 1, 2026, for QuantaBio DNA extraction reagents supporting newborn screening for Severe Combined Immunodeficiency Disorder and Spinal Muscular Atrophy, with bids due July 15, 2026 and historical spend of $2.5 million over a three-month prior period; HHSC also posted IFB HHS0016959 in April 2026 for digital PCR instruments with DNA extraction capability (QIAcuity and EZ2 Connect MDx systems) with historical estimated value of $100,000 to $200,000. Mississippi Forensic Laboratory posted RFI 1711-26-R-RFIN-00013 on June 30, 2026, for Life Technologies kits and reagents (proposals due July 21, 2026), and the State of Mississippi posted a sole-source procurement in March 2026 for Qiagen EZ1 and 2DNA kits. Illinois State Police posted IFB B-51025 in February 2026 for a nine-year contract supplying PowerPlex STR amplification kits to nine designated forensic laboratory locations across the state.